RFCL to make hematology reagents for Diagon

RFCL, Gurgaon-headquartered biosupplier has signed a technology transfer agreement with Hungarian clinical diagnostic manufacturing company, Diagon. The former will accept the formulation and technology inputs for manufacturing of reagents for the leading 3-part and 5-part differential instruments at the new manufacturing facility of Diagnova, RFCL in Dehradun.

RFCL's strategic business unit, Diagnova, will manufacture and sell these reagents in India to competitors like Mindray, Sysmex, Coulter, and will be used in Diagnova’s own installations of Lablife Noble III, H3D, D5 Supreme.

The manufacturing plant is dedicated for manufacturing in vitro diagnostics (IVD) products, and comprises of separate facilities for manufacturing of diagnostic kits/reagents which include biochemistry, immunology, serology, rapid card tests and hematology, to produce a range of products in different SKUs.

The entire facility has been designed as per latest cGMP requirements, approved by the State FDA. The facility is accredited with ISO 9001:2008, ISO 14000:2004, and is in the process of obtaining the ISO-134854 and CE certification.

Thermo Fisher opens tech center in China
Thermo Fisher Scientific, a major technology provider to the life sciences industry, has opened a technology center in Shanghai (China), building on its engineering and development capabilities, to meet the specific needs of customers in China. The center houses engineers and support staff, focused on developing a robust product pipeline to serve China-based customers across a range of industries.

"The China Technology Center is another step in our ongoing investment to expand our operations there, and leverage our depth of capabilities to develop and manufacture products in China for China," said Marc N Casper, president and CEO, Thermo Fisher Scientific.

The China Technology Center, along with a new demonstration center in Beijing, China, is part of Thermo Fisher's continuing strategy to align with the leading educational, industrial and commercial initiatives in the region. The company first entered the China market 30 years ago, and began to establish an extensive manufacturing footprint shortly thereafter.

EMD Millipore, Luminex in distribution deal
EMD Millipore, the life sciences division of Germany's Merck, has commenced worldwide distribution of the new Magpix system, from US-based multiplex technology leader Luminex.

EMD Millipore acquired the original Luminex reagent partners – Linco and Upstate – for life sciences research in 2006. Since that acquisition, the company has strengthened its commitment to the xMAP platform through its growing line of Milliplex Map kits, analysis software, and global salesforce.

Based on Luminex's xMAP Technology, the easy-to-use, low-maintenance Magpix instrument is compact – comparable in size to a desktop computer – making it attractive to smaller and lower-volume laboratories and institutions with limited resources and bench space. The instrument is said to provide fast, accurate and easily reproducible results, helping to advance research across many disease states such as metabolic, inflammation, toxicity and neuroscience, as well as applications in oncology and cell signaling.